Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.
about
COMT polymorphism modulates the resting-state EEG alpha oscillatory response to acute nicotine in male non-smokersNeural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targetsEvaluation of state and trait biomarkers in healthy volunteers for the development of novel drug treatments in schizophrenia.From attention to memory along the dorsal-ventral axis of the medial prefrontal cortex: some methodological considerations.Methamphetamine-induced psychosis is associated with DNA hypomethylation and increased expression of AKT1 and key dopaminergic genes.Finding what you are not looking for: strategies for developing novel treatments in psychiatry.Introduction: genes, cognition and neuropsychiatry.
P2860
Q35887978-59CD1DC1-C25D-45B7-8388-28CD8BFD979CQ36401907-0592E310-B6F4-49A0-9052-2A95E0EE6D7DQ37945156-F954A67F-D757-4D7E-A366-56D5014AE744Q38253630-6F3785B1-E712-4ABB-916B-2447CDF0F2C1Q38810082-5FD68237-AD50-4ADA-A217-3681C8C81729Q41358274-87CC722B-2448-4F59-A42B-DEC582DEA626Q45919191-5596B54A-3CA1-4E7A-8E06-D76230B2D146
P2860
Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.
@ast
Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.
@en
type
label
Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.
@ast
Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.
@en
prefLabel
Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.
@ast
Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.
@en
P2860
P1433
P1476
Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.
@en
P2093
José A Apud
P2860
P304
P356
10.1016/J.NURX.2005.12.004
P577
2006-01-01T00:00:00Z